The DEA is meant to fill the role of defending the reform, while only opponents of resecheduling have been invited to ...
The cannabis industry won't have a direct voice in potentially historic hearings next week. And a final outcome is far from certain.
"The Future of Marijuana Rescheduling Will Ultimately Be Decided by Federal Judges, Not Administrative Witnesses" says Duane ...
Three Republican attorneys general are asking a federal appeals court to block the Trump administration's push to reschedule ...
The rescheduling of medical cannabis to Schedule III has paradoxically created significant uncertainty for banks serving the ...
This presentation provides a 2024 - 2025 update on cannabis policy, highlighting pivotal federal and state developments and examining their implications for the industry and society. First, we will ...
A DEA hearing to consider marijuana rescheduling will hear evidence and testimony only from cannabis reform's enemies, the agency said.
The proposed rescheduling of cannabis currently under consideration by the Department of Health and Human Services, the Department of Justice and the Drug Enforcement Agency would move it from ...
Tilray Brands is back in focus as analysts reset their thinking on where the stock might be headed, with some firms cutting price targets in both US$ and C$ while others keep their fair value view ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results